ClinConnect ClinConnect Logo
Search / Trial NCT06497881

Upper Limb Movement Quality Following Stroke

Launched by ADI NEGEV-NAHALAT ERAN · Jul 10, 2024

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial, titled "Upper Limb Movement Quality Following Stroke," is studying how well people who have had a stroke can move their arms. The researchers want to see how daily arm movements relate to recovery and improvement in their overall condition. The trial is currently looking for participants aged 18 and older who were independent in their daily activities before their stroke and are now receiving treatment at the Adi-Negev Nahalat-Eran rehabilitation center.

To be eligible, participants must be medically stable and able to give their consent. However, those with certain other neurological conditions, serious psychiatric issues, or severe physical limitations may not qualify. If you join this study, you can expect to monitor your arm movements over time and help researchers understand how these movements relate to recovery after a stroke. Your participation could contribute to better treatment options for stroke recovery in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • \>18 years of age
  • Independent in all activities of daily living before the stroke.
  • In- and out-patients at Adi-Negev Nahalat-Eran rehabilitation center.
  • Medically stable
  • Able to provide informed consent.
  • Exclusion Criteria:
  • The presence of any degenerative neurological condition, neuropathy, myopathy or Polio that are not secondary to stroke, excluding diabetic related changes.
  • Traumatic brain injury and/or extra-cerebral hemorrhage.
  • Significant psychiatric condition, including alcoholism and drug abuse.
  • Any severe orthopedic condition (such as amputation or severe pain that limits activity) or chronic pain syndrome.

About Adi Negev Nahalat Eran

Adi Negev-Nahalat Eran is a pioneering clinical trial sponsor dedicated to advancing innovative therapeutic solutions for individuals with complex neuropsychiatric conditions. With a strong commitment to research excellence and patient-centered care, the organization collaborates with leading academic institutions and healthcare providers to design and conduct rigorous clinical studies. Their focus on evidence-based approaches aims to enhance treatment outcomes and improve the quality of life for patients, while also contributing to the broader scientific community through the dissemination of research findings.

Locations

Ofakim, , Israel

Patients applied

0 patients applied

Trial Officials

Lior Smuelof, PhD

Principal Investigator

Ben-Gurion University of the Negev

Yogev Koren, PhD

Principal Investigator

Ben-Gurion University of the Negev

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported